Full Text Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Dunn, L. B. Articles by Appelbaum, P. S. Search for Related Content PubMed Citation Articles by Dunn, L. B. Articles by Appelbaum, P. S. Neuropsychology Geriatric Psychiatry Informed Consent Other Ethics Issues Schizophrenia Spectrum Disorders Cognition

Assessment of Therapeutic Misconception in Older Schizophrenia Patients With a Brief Instrument

OBJECTIVE: "Therapeutic misconception," or conflation of goals and procedures of clinical research with those of usual clinical care, is an important topic in research ethics because it may impede informed consent. How best to assess therapeutic misconception is unclear. Also unclear is to what degree patients with severe mental illnesses, such as schizophrenia, may manifest these beliefs. METHOD: With a hypothetical, double-blind, placebo-controlled trial as a stimulus, the authors examined the frequency of a key aspect of therapeutic misconception with a true/false scale in 87 middle-age and older patients with schizophrenia or schizoaffective disorder. They also analyzed the demographic, clinical, neurocognitive, and decision-making correlates of therapeutic misconception and examined the psychometric properties of a scale designed to measure therapeutic misconception. RESULTS: Subjects showed variable performance on the therapeutic misconception measure. Nearly one-third answered all questions correctly; two-thirds answered four or more of the six items correctly. Patients with less education or worse cognitive functioning manifested higher levels of therapeutic misconception. Degree of therapeutic misconception was inversely associated with understanding, appreciation, and reasoning scores on the MacArthur Competence Assessment Tool for Clinical Research but was not associated with severity of psychopathology. The scale showed fair internal consistency. CONCLUSIONS: As in studies of other patient populations, patients with schizophrenia show a substantial incidence of beliefs associated with therapeutic misconception. Further work should focus on refining measures of therapeutic misconception, identifying participants or protocols (e.g., higher-risk studies) in which it may warrant greater concern, and developing educational interventions to mitigate it.

This article has been cited by other articles:

				A Charuvastra and S R Marder Unconscious emotional reasoning and the therapeutic misconception J. Med. Ethics, March 1, 2008; 34(3): 193 - 197. [Abstract] [Full Text] [PDF]

				I de Melo-Martin and A Ho Beyond informed consent: the therapeutic misconception and trust J. Med. Ethics, March 1, 2008; 34(3): 202 - 205. [Abstract] [Full Text] [PDF]

				L. B. Dunn, D. S. Kim, I. E. Fellows, and B. W. Palmer Worth the Risk? Relationship of Incentives to Risk and Benefit Perceptions and Willingness to Participate in Schizophrenia Research Schizophr Bull, February 14, 2008; (2008) sbn003v1. [Abstract] [Full Text] [PDF]

				D. V. Jeste, B. W. Palmer, P. S. Appelbaum, S. Golshan, D. Glorioso, L. B. Dunn, K. Kim, T. Meeks, and H. C. Kraemer A New Brief Instrument for Assessing Decisional Capacity for Clinical Research Arch Gen Psychiatry, August 1, 2007; 64(8): 966 - 974. [Abstract] [Full Text] [PDF]

				B. Resnick, A. L. Gruber-Baldini, I. Pretzer-Aboff, E. Galik, V. C. Buie, K. Russ, and S. Zimmerman Reliability and Validity of the Evaluation to Sign Consent Measure Gerontologist, February 1, 2007; 47(1): 69 - 77. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us